Fully Human Anti-HCMV Antibody


Intended to be used for prophylaxis of human cytomegalovirus (HCMV) infection

Product Advantage

A natural fully human antibody drug with HCMV neutralizing activity


Innovative biological agent; patent of Natural Fully Human Monoclonal Antibody R&D Platform

Product Introduction

Fully Human Anti-HCMV Antibody can neutralize free virus in blood and has the capacity for neutralization within cells twice. Currently, there is no HCMV vaccine launched in the world. The product has a precise mechanism of action and excellent safety, and can be produced on a large scale under strict quality control due to its non-blood-derived production process. It is expected to fill the gap of HCMV monoclonal antibodies in the world.